Specialty Pharmacy

Nivolumab plus ipilimumab deemed tolerable in non-small cell lung cancer patients, with notable improvements in safety.

Billions wasted each year from lack of adherence to prescription medications.

Combination drugs may cause adverse events in individuals coinfected with HIV and HCV.

Study findings may improve the prevention and treatment of rheumatoid arthritis.

Combination cancer drug shows the potential to help with fertility in the future.

Babies born with low levels of vitamin D face an increased risk of developing MS in the future.

Top articles of 2016 on Specialty Pharmacy Times.

Pharmaceutical manufacturers historicially reaped the benefits of operating independently in pricing and discounting drugs based on volume sold in the United States.

Anti-vascular endothelial growth factor agents are the criterion standard for diabetic macular edema.

Thioguanine and decitabine combination therapy show positive results in phase 1 trial.

A single dose of an experimental gene therapy led to maintained factor levels about 30% of patients with hemophilia B.

The cause of a rare sarcoma may provide a promising new treatment target for soft tissue cancer.

Patients with serious illness who receive palliative care were more satisfied with their health care.

Top HCV articles of the year on Specialty Pharmacy Times.

Reovirus could treat liver diseases such as hepatitis C virus and primary liver cancer.

Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses effective measures for maintaining adherence to specialty drug regimens.

Top HIV articles of the year on Specialty Pharmacy Times.

Medical marijuana could potentially be used to treat drug addiction and certain mental health conditions.

Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at UIC College of Pharmacy, discusses the challenges patients face when starting a specialty medication regimen.

Patients share their personal stories with Specialty Pharmacy Times.

Interaction among probiotics and an intrinsic gut microbiota may influence atopic dermatitis.

Out-of-pocket costs may prevent patients with chronic illnesses from purchasing some Affordable Care Act plans.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses challenges in gaining access to cholesterol-lowering PCSK9 inhibitors.

Top news of the week in oncology and cancer drug development.

Proton pump inhibitors combined with a certain chemotherapy drug may lower the possibility for cancer patients to recover and survive.

HCV patients without cirrhosis achieved SVR after 8 weeks of treatment with glecaprevir/pibrentasvir.

Emicizumab prophylaxis reduced the number of bleeds in hemophilia A patients.

Top articles of the week from Specialty Pharmacy Times.